Aytu BioPharma Inc

Aytu BioPharma Inc

AYTU

Get informed when a big investor buys or sells

+ Follow
Market Cap$24.47M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Aytu BioPharma IncAytu BioPharma Inc-2--40%0.60.5
$-1.88

Current Fair Value

185.3% downside

Overvalued by 185.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$24.47 Million
Enterprise Value$16.27 Million
Dividend Yield$- (-)
Earnings per Share$-1.16
Beta0.27
Outstanding Shares12,318,817

Return

Return on Equity-40.40%ROE
Return on Assets-13.57%
Return on Invested Capital-36.33%

Valuation & Multiples

P/E Ratio-1.97P/E Ratio
PEG1.97PEG
Price to Sales0.55Price to Sales
Price to Book Ratio1.1Price to Book Ratio
Enterprise Value to Revenue0.28
Enterprise Value to EBIT-0.89
Enterprise Value to Net Income-2
Total Debt to Enterprise1.11
Debt to Equity0.51Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
September 29, 2026
EPS Estimate
$-0.29
Average shareholder expectation
Revenue Estimate
$12.28 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 12, 2026
EPS Estimate
$-0.34
Average shareholder expectation
Revenue Estimate
$12.66 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %36.49%▼ 1.11%
Total Invested$8.25M▼ 43.67%
Investors Holding36▲ 1.00%

ESG Score

No data

About Aytu BioPharma Inc

75 employees